New Sermo survey of Covid-19 treaters released yesterday:
*Hydroxychloroquine use in NY has doubled since March 25.
*HCQ continues to grow.
*HCQ and plasma seen as the most successful treatments.
The top treatments that have been used/seen used and reported as very or extremely effective among COVID treaters (N= 1337) include:
46% plasma from recovered patients (n=363); 40% Hydroxychloroquine (n=875); 38% high dose steroids during a cytokine storm (n=556)
- Usage of anti-HIV drugs (e.g. Lopinavir plus Ritonavir), drugs to treat the flu (e.g. Oseltamivir), and plasma from recovered patients remains steady week over week, while use of non-approved drugs (e.g. Remdesivir) decreased slightly.
- Survey: Physicians who treat COVID patients in Italy, Spain, France, and China have higher perceptions of Hydroxychloroquine’s efficacy vs the US (~50% vs 29%).
- Survey: Italy and France had the highest increase in COVID treaters having prescribed Hydroxychloroquine wave over wave; an increase from 50% to 83% for Italy and an increase from 20% to 50% for France.
“Interesting that those on the front lines currently see Remdesivir as less effective than hydroxychloroquine or even steroids.” - analysis
https://www.sermo.com/press-releases/category/week-of-0413/
Thanks.